Dupilumab significantly reduced airway inflammation in patients with uncontrolled, moderate-to-severe type 2 asthma. Read now.

Researchers found increased odds for clinical remission on dupilumab with high blood eosinophil and fractional exhaled nitric ...

Patients with chronic spontaneous urticaria that was not controlled with H1 antihistamines experienced improvements in itch and urticaria activity with dupilumab, according to a poster presented here.

Reslizumab may also prove to be efficacious in patients with a similar asthma phenotype. Dual inhibition of IL-4 and IL-13 with dupilumab represents a very promising avenue for biologic-based ...

Biologic treatment for atopic dermatitis appeared to improve growth trajectories for younger children, a trial analysis ...

Discover a proof-of-concept study that was conducted to explore whether dupilumab could induce desensitisation to peanut.

1 Dupilumab Development Program Dupilumab is ... or inhaled corticosteroid medicines; have asthma and use an asthma medicine; or have atopic dermatitis, chronic rhinosinusitis with nasal polyps ...